You are using an older browser version. Please use a supported version for the best MSN experience.

21 Stocks Moving In Tuesday's Pre-Market Session

Benzinga logo Benzinga 11/23/2021 Lisa Levin
© Provided by Benzinga


Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 201% to $4.00 in pre-market trading. The company filed proxy statement for annual meeting after the market close on Monday. iSpecimen Inc. (NASDAQ: ISPC) rose 103.8% to $18.10 in pre-market trading. iSpecimen shares jumped more than 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. Qualigen Therapeutics, Inc. (NASDAQ: QLGN) rose 93.6% to $2.42 in pre-market trading as traders circulated a Zack's Small Cap research note showing a $9 price target on the stock. Bit Brother Limited (NASDAQ: BTB) rose 43.5% to $1.23 in pre-market trading after dropping over 12% on Monday. Allied Esports Entertainment Inc. (NASDAQ: AESE) shares rose 15.2% to $2.20 in pre-market trading after the company reported a narrower quarterly loss. The company also highlighted that 'the Company is continuing to identify opportunities to invest the cash on its balance acquire or merge with an existing business.' Quantum-Si incorporated. (NASDAQ: QSI) rose 11.4% to $7.59 in pre-market trading after dropping 10% on Monday. Quantum-Si recently posted a Q3 loss of $0.13 per share. RLX Technology Inc. (NYSE: RLX) rose 11.4% to $5.48 in pre-market trading after climbing 9% on Monday. Iterum Therapeutics plc (NASDAQ: ITRM) rose 10.6% to $0.5090 in pre-market trading after declining 7% on Monday. Iterum Therapeutics recently posted Q3 EPS of $0.02. Longeveron Inc. (NASDAQ: LGVN) rose 9.5% to $30.87 in pre-market trading on continued upward momentum after the company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares rose 9.5% to $0.5095 in pre-market trading. Tonix Pharmaceuticals reported publication of paper on antiviral SARS-CoV-2 inhibitor, TNX-3500, in JCI Insight. Soligenix, Inc. (NASDAQ: SNGX) rose 7.2% to $0.89 in pre-market trading. Soligenix recently posted a Q3 loss of $0.09 per share.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers


Reliance Global Group, Inc. (NASDAQ: RELI) shares fell 17.5% to $1.74 in pre-market trading. Reliance Global Group promoted Jonathan Fortman to Vice President of Acquisitions. BioHiTech Global, Inc. (NASDAQ: BHTG) fell 15.3% to $0.80 in pre-market trading after declining 8% on Monday. BioHiTech Global, last week, said Q3 EPS and sales results were higher year over year. Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) fell 13.8% to $0.7590 in pre-market trading. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million. Urban Outfitters, Inc. (NASDAQ: URBN) fell 13.3% to $32.32 in pre-market trading. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter. PainReform Ltd. (NASDAQ: PRFX) fell 12.5% to $2.01 in pre-market trading. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021. iPower Inc. (NASDAQ: IPW) shares fell 9% to $2.74 in pre-market trading after dropping over 9% on Monday. iPower recently entered into $25 million credit facility with JPMorgan Chase. Zoom Video Communications, Inc. (NASDAQ: ZM) fell 8.7% to $221.19 in pre-market trading. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. Progenity, Inc. (NASDAQ: PROG) shares fell 8.3% to $4.08 in pre-market trading following a 9% decline in the previous session. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares fell 7.2% to $17.58 in pre-market trading after declining 28% on Monday. Oramed's Oravax Medical Unit recently reported a joint venture with Genomma Lab to develop, commercialize oral COVID-19 vaccine in Mexico. Borr Drilling Limited (NYSE: BORR) shares fell 7.2% to $1.03 in pre-market trading. Borr Drilling, earlier in November, reported better-than-expected Q3 EPS results.

More From Benzinga

image beaconimage beaconimage beacon